UMB Bank n.a. Grows Position in The Chemours Company (NYSE:CC)

UMB Bank n.a. increased its position in The Chemours Company (NYSE:CC) by 73.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,231 shares of the specialty chemicals company’s stock after purchasing an additional 948 shares during the quarter. UMB Bank n.a.’s holdings in Chemours were worth $30,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Corient Private Wealth LLC lifted its stake in shares of Chemours by 4.7% in the 4th quarter. Corient Private Wealth LLC now owns 13,428 shares of the specialty chemicals company’s stock valued at $227,000 after purchasing an additional 604 shares during the period. HUB Investment Partners LLC raised its stake in Chemours by 1.4% during the fourth quarter. HUB Investment Partners LLC now owns 58,250 shares of the specialty chemicals company’s stock valued at $984,000 after buying an additional 821 shares during the last quarter. Itau Unibanco Holding S.A. raised its stake in Chemours by 39.3% during the fourth quarter. Itau Unibanco Holding S.A. now owns 3,554 shares of the specialty chemicals company’s stock valued at $60,000 after buying an additional 1,003 shares during the last quarter. Quadrant Capital Group LLC raised its stake in Chemours by 100.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 1,119 shares during the last quarter. Finally, Captrust Financial Advisors raised its stake in Chemours by 9.7% during the fourth quarter. Captrust Financial Advisors now owns 13,130 shares of the specialty chemicals company’s stock valued at $222,000 after buying an additional 1,165 shares during the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Royal Bank of Canada decreased their price target on Chemours from $17.00 to $14.00 and set an “outperform” rating for the company in a research note on Thursday, May 8th. Truist Financial cut their price objective on Chemours from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, April 14th. Mizuho set a $15.00 price objective on Chemours in a report on Tuesday, April 15th. Wall Street Zen lowered Chemours from a “hold” rating to a “sell” rating in a report on Wednesday, May 21st. Finally, Barclays cut their price objective on Chemours from $16.00 to $13.00 and set an “equal weight” rating for the company in a report on Wednesday, May 28th. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $17.22.

Insider Buying and Selling

In related news, insider Damian Gumpel acquired 13,400 shares of the firm’s stock in a transaction on Monday, June 2nd. The shares were acquired at an average cost of $9.22 per share, for a total transaction of $123,548.00. Following the completion of the transaction, the insider now directly owns 123,879 shares in the company, valued at approximately $1,142,164.38. This trade represents a 12.13% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Shane Hostetter bought 4,450 shares of the business’s stock in a transaction dated Monday, May 19th. The shares were acquired at an average cost of $11.28 per share, for a total transaction of $50,196.00. Following the purchase, the chief financial officer now owns 59,694 shares of the company’s stock, valued at approximately $673,348.32. The trade was a 8.06% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 25,672 shares of company stock worth $251,573. Corporate insiders own 0.47% of the company’s stock.

Chemours Stock Performance

NYSE:CC opened at $10.98 on Monday. The stock has a 50-day simple moving average of $11.24 and a two-hundred day simple moving average of $14.95. The Chemours Company has a 52-week low of $9.13 and a 52-week high of $25.54. The firm has a market capitalization of $1.64 billion, a PE ratio of 19.26 and a beta of 1.64. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same quarter in the previous year, the firm earned $0.32 earnings per share. Chemours’s revenue was up .4% on a year-over-year basis. Analysts forecast that The Chemours Company will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The company also recently announced a dividend, which will be paid on Monday, June 16th. Investors of record on Monday, May 19th will be given a $0.0875 dividend. The ex-dividend date is Friday, May 16th. This represents a dividend yield of 3.17%. Chemours’s dividend payout ratio is currently 175.00%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.